Clinical Research on Transcatheter Intervention for Congenital Heart Diseases of 2002 Cases

来源 :第六届亚太儿科心脏协会年会 | 被引量 : 0次 | 上传用户:chenke
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
其他文献
Introduction: To analyse the time,possible reason and treatment of thrombocytopenia after interventional postoperative of congenital heart disease.
目的:探讨Amplatzer 第二代动脉导管未闭封堵器(amplatzer ductoccluder,ADO Ⅱ)在非动脉导管病变中应用的安全性和有效性.方法:2011 年5 月至2015年10 月28 例患者应用ADO Ⅱ 治疗非动脉导管病变,封堵后观察封堵器的位置,形态及封堵效果.结果:28 例非动脉导管病变的病例应用ADO Ⅱ 封堵手术均成功.年龄在5 月-42岁(平均13.0±17.2 年
会议
会议
会议
Objective: Analyze the curative effect of percutaneous balloon pulmonary valve(PBPV)in the treatment of children with pulmonary valve stenosis(PS),to improve the cure rate and reduce the complications
Objective To explore the efficacy and safety of transcatheter closure of congenital ventricular septal defect using the Ampatzer duct occluder Ⅱ(ADOⅡ).
Objective To get the reason for the changes of echocardiography between preoperation and postoperative 24 hours in 102 with the percutaneous transcatheter closure of patent ductus arteriosus(PDA).
Objective: To explore the feasibility and safety of transcatheter closure of ventricular septal defect(VSD)with deficient aortic rim.